BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 310 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $272,000 | -91.2% | 1,870 | -92.8% | 0.04% | -87.6% |
Q1 2022 | $3,075,000 | -47.5% | 25,934 | -38.9% | 0.36% | -42.3% |
Q4 2021 | $5,854,000 | -22.1% | 42,478 | -21.5% | 0.63% | -22.3% |
Q3 2021 | $7,519,000 | +25.3% | 54,125 | -12.4% | 0.81% | +25.9% |
Q2 2021 | $5,999,000 | +49.2% | 61,794 | +5.1% | 0.64% | +41.4% |
Q1 2021 | $4,020,000 | -22.2% | 58,811 | -2.4% | 0.46% | -23.7% |
Q4 2020 | $5,166,000 | +27.0% | 60,276 | -3.7% | 0.60% | +7.0% |
Q3 2020 | $4,067,000 | -18.9% | 62,560 | -8.8% | 0.56% | -25.3% |
Q2 2020 | $5,013,000 | +30.1% | 68,563 | -39.5% | 0.75% | +2.9% |
Q1 2020 | $3,854,000 | +8.0% | 113,251 | +72.8% | 0.73% | +59.4% |
Q4 2019 | $3,568,000 | +42.3% | 65,533 | +9.0% | 0.46% | +29.9% |
Q3 2019 | $2,508,000 | -30.0% | 60,126 | -26.6% | 0.35% | -25.8% |
Q2 2019 | $3,585,000 | +64.2% | 81,868 | +93.0% | 0.47% | +60.9% |
Q1 2019 | $2,183,000 | +33.8% | 42,422 | -3.9% | 0.29% | -3.9% |
Q4 2018 | $1,632,000 | +63.9% | 44,140 | +66.5% | 0.31% | +137.2% |
Q3 2018 | $996,000 | +21.9% | 26,515 | +28.2% | 0.13% | -6.5% |
Q2 2018 | $817,000 | – | 20,685 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $108,659,000 | 54.35% |
Knoll Capital Management, LLC | 749,815 | $38,593,000 | 29.33% |
VHCP Management II, LLC | 1,138,075 | $58,577,000 | 17.14% |
ORACLE INVESTMENT MANAGEMENT INC | 1,021,392 | $52,571,000 | 11.19% |
Aisling Capital Management LP | 274,513 | $14,129,000 | 10.76% |
Foresite Capital Management IV, LLC | 518,560 | $26,690,000 | 9.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 844,266 | $43,454,000 | 5.81% |
ACUTA CAPITAL PARTNERS, LLC | 206,000 | $10,603,000 | 5.04% |
ARS Investment Partners, LLC | 464,127 | $23,889,000 | 4.32% |
Cormorant Asset Management, LP | 1,100,000 | $56,617,000 | 3.83% |